| scholarly article | Q13442814 |
| P2093 | author name string | Douglas W Mapel | |
| Jenõ P Marton | |||
| P2860 | cites work | Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data | Q33827577 |
| Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization | Q34041644 | ||
| The relationship between pulmonary emphysema and kidney function in smokers | Q36212650 | ||
| Prevalence of multiple chronic conditions in the United States' Medicare population | Q37356138 | ||
| Predicting the costs of managing patients with chronic obstructive pulmonary disease | Q40391805 | ||
| The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway | Q43517209 | ||
| Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. | Q43973658 | ||
| Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients | Q45729210 | ||
| Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. | Q48380183 | ||
| Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. | Q51839413 | ||
| Serum Bilirubin and Risk of Respiratory Disease and Death | Q56946006 | ||
| Utilization in COPD: patient characteristics and diagnostic evaluation | Q73870496 | ||
| High COPD prevalence in patients with liver disease | Q82970920 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatobiliary disease | Q2755530 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 127-134 | |
| P577 | publication date | 2013-03-15 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. | |
| P478 | volume | 8 |
| Q38267946 | Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology. |
| Q91835368 | Consequences of chronic kidney disease in chronic obstructive pulmonary disease |
| Q58131508 | Determination of colistin-related nephrotoxicity and risk factors in intensive care unit |
| Q35825585 | Economic Burden of COPD in the Presence of Comorbidities. |
| Q38848702 | Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease |
| Q39884619 | Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study |
| Q40103591 | Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q91650688 | Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study |
| Q95641902 | Management of the COPD Patient with Comorbidities: An Experts Recommendation Document |
| Q27005858 | Managing comorbidities in COPD |
| Q28387680 | Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012 |
| Q36202909 | Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q57213589 | Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010 |
| Q93027457 | Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review |
| Q45711435 | Systemic tentacles of chronic obstructive pulmonary disease: do we need to account for renal damage? |
Search more.